Reslizumab Completed Phase 3 Trials for Asthma Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02452190 | Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils |